RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
14.25
+1.06 (8.04%)
At close:
Jan 27, 2023, 4:00 PM
14.96
+0.71 (4.98%)
After-hours:
Jan 27, 2023, 7:11 PM EST
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue
|
22.59 | 14.68 | 2.24 |
| Revenue Growth (YoY)
|
53.92% | 554.98% | - |
| Cost of Revenue
|
18.08 | 12.97 | 4.06 |
| Gross Profit
|
4.52 | 1.71 | -1.82 |
| Selling, General & Admin
|
32.81 | 15.18 | 15.2 |
| Research & Development
|
24.5 | 21.93 | 29.57 |
| Other Operating Expenses
|
0 | 0.01 | -0.52 |
| Operating Expenses
|
57.3 | 37.12 | 44.25 |
| Operating Income
|
-52.79 | -35.41 | -46.07 |
| Interest Expense / Income
|
3.68 | 0.51 | 0.03 |
| Other Expense / Income
|
-7.79 | -63.55 | -172.34 |
| Pretax Income
|
-48.68 | 27.63 | 126.24 |
| Income Tax
|
0.01 | 0.06 | 0.02 |
| Net Income
|
-48.69 | 27.58 | 126.22 |
| Preferred Dividends
|
0 | 24.21 | 100.09 |
| Net Income Common
|
-48.69 | 3.37 | 26.13 |
| Net Income Growth
|
- | -87.12% | - |
| Shares Outstanding (Basic)
|
14 | 4 | - |
| Shares Outstanding (Diluted)
|
14 | 6 | - |
| Shares Change
|
146.28% | - | - |
| EPS (Basic)
|
-3.57 | 0.91 | - |
| EPS (Diluted)
|
-3.57 | 0.15 | - |
| Free Cash Flow Per Share
|
-3.42 | -10.18 | - |
| Gross Margin
|
19.99% | 11.62% | -81.17% |
| Operating Margin
|
-233.64% | -241.26% | -2055.78% |
| Profit Margin
|
-215.50% | 22.93% | 1165.86% |
| Free Cash Flow Margin
|
-206.47% | -257.11% | -1967.96% |
| Effective Tax Rate
|
- | 0.21% | 0.02% |
| EBITDA
|
-41.01 | 32.15 | 130.2 |
| EBITDA Margin
|
-181.52% | 219.06% | 5809.91% |
| Depreciation & Amortization
|
3.99 | 4.01 | 3.93 |
| EBIT
|
-45 | 28.14 | 126.27 |
| EBIT Margin
|
-199.17% | 191.73% | 5634.54% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).